Decode
Reykjavik, IS · 1 known investors
deCODE analyzes and interprets the human genome to identify genetic risk factors for common diseases including cardiovascular disease and cancer. The company serves pharmaceutical and research organizations through genomic discovery and analysis.
AI & Machine LearningBiotechDeep Tech
Investors · 1
In the news
- Decode - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2026
- Decode Age Raises ₹14.48 crore in Pre Series A funding to Advance Longevity Science and Gut Microbiome Researchstartuptalky.com · 2025
- Decode Age raises ₹14.48 crore in pre-Series A funding roundmarcamoney.com · 2025
- Decode Age Raises $1.7 Million to Advance Longevity Sciencesiliconindia.com